The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric Plasma
Open accessAbstract
Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Despite multimodal treatments including surgery, chemotherapy and radiotherapy the prognosis remains poor and relapse occurs regularly. The alkylating agent temozolomide (TMZ) has been shown to improve the overall survival in patients with malignant gliomas, especially in tumors with methylated promoter of the O6-methylguanine-DNA-methyltransferase (MGMT) gene. However, intrinsic and acquired resistance towards TMZ makes it crucial to find new therapeutic strategies aimed at improving the prognosis of patients suffering from malignant gliomas. Cold atmospheric plasma is a new auspicious candidate in cancer treatment. In the present study we demonstrate the anti-cancer properties of different dosages of cold atmospheric plasma (CAP) both in TMZ-sensitive and TMZ-resistant cells by proliferation assay, immunoblotting, cell cycle analysis, and clonogenicity assay. Importantly, CAP treatment restored the responsiveness of resistant glioma cells towards TMZ therapy. Concomitant treatment with CAP and TMZ led to inhibition of cell growth and cell cycle arrest, thus CAP might be a promising candidate for combination therapy especially for patients suffering from GBMs showing an unfavorable MGMT status and TMZ resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Cited by
Cold atmospheric plasma, a novel promising anti-cancer treatment modality
Yan, D., Sherman, J. H., & Keidar, M. (2017) · Oncotarget · doi:10.18632/oncotarget.13304 · Cited by 543
Keidar, M. (2015) · Plasma Sources Science and Technology · doi:10.1088/0963-0252/24/3/033001 · Cited by 438
Non-Thermal Atmospheric-Pressure Plasma Possible Application in Wound Healing
Haertel, B., Woedtke, T. V., Weltmann, K.-D., & Lindequist, U. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.105 · Cited by 433
Van der Paal, J., Neyts, E. C., Verlackt, C. C. W., & Bogaerts, A. (2016) · Chemical Science · doi:10.1039/c5sc02311d · Cited by 413
Cold Plasma in Medicine and Healthcare: The New Frontier in Low Temperature Plasma Applications
Laroussi, M. (2020) · Frontiers in Physics · doi:10.3389/fphy.2020.00074 · Cited by 319
Metadata
- Authors
- Köritzer, J., Boxhammer, V., Schäfer, A., Shimizu, T., Klämpfl, T. G., Li, Y.-F., Welz, C., Schwenk-Zieger, S., Morfill, G. E., Zimmermann, J. L., & Schlegel, J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-21
- Volume
- 8
- Issue
- 5
- Pages
- e64498
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2075633900
- Cited by
- 249
- References
- 1
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric Plasma. https://app.cochat.ai/papers/10.1371/journal.pone.0064498
- The paper
- Köritzer, J., Boxhammer, V., Schäfer, A., Shimizu, T., Klämpfl, T. G., Li, Y.-F., Welz, C., Schwenk-Zieger, S., Morfill, G. E., Zimmermann, J. L., & Schlegel, J. (2013). Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric Plasma. PLoS ONE. https://doi.org/10.1371/journal.pone.0064498
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.